Authors
Ranhao Li, Hongxia Mai, Wenjun Zhang
Published in
American journal of nephrology. Oct 10, 2026. Epub Oct 10, 2026.
Abstract
Solitary functioning kidney (SFK) is a clinical condition characterized by the presence of a single functioning kidney, arising from either congenital anomalies or acquired causes. It is recognized as an important risk factor for chronic kidney disease and, in some patients, progression to end-stage kidney disease. Previous publications have often addressed pediatric congenital SFK, living kidney donors, and disease-related nephrectomy cohorts separately, limiting the translation of heterogeneous evidence into a common clinical approach.
This review integrates evidence on congenital and acquired SFK across the life course, covering etiology, pathophysiology, diagnostic assessment, risk factors, and long-term management. Despite differences in developmental background, timing of adaptation, and comorbidity burden, both conditions involve reduced functional nephron mass and compensatory adaptations. Renal enlargement and glomerular hyperfiltration initially preserve kidney function but may become maladaptive, contributing to glomerular injury, proteinuria, tubulointerstitial inflammation, and fibrosis. Ultrasonography, blood pressure measurement, urinary albumin or protein assessment, and estimated glomerular filtration rate remain central to clinical evaluation, whereas most emerging biomarkers require further validation. Prognostic assessment should integrate established kidney injury with etiology-specific indicators of renal reserve and additional renal insults.
Persistent albuminuria or proteinuria, hypertension, and declining kidney function are the principal clinical indicators of adverse renal outcomes in SFK. We propose an evidence-informed, two-step framework that first identifies established kidney injury and then assesses residual renal reserve and additional "second hits" to guide dynamic risk stratification and individualized follow-up. Management should emphasize appropriate lifestyle measures, blood pressure and proteinuria control, and avoidance of additional nephrotoxic insults, with pharmacological therapy guided by kidney injury and comorbidities. The proposed framework complements established CKD classification and population-specific recommendations but remains conceptual and requires prospective validation.
PMID:
43049069
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0